In vitro generation of platelets: Where do we stand?

Area of Science:

• Hematology
• Biomedical Engineering
• Cell Biology

Background:

• Platelets are crucial for hemostasis and inflammation, but their limited supply poses a challenge for transfusions and treating platelet disorders.
• Megakaryopoiesis, the process of platelet production by megakaryocytes, is regulated by bone marrow microenvironment and factors like Thrombopoietin.
• Current understanding of megakaryocyte development and platelet production mechanisms is insufficient for developing cures for life-threatening platelet diseases.

Purpose of the Study:

• To develop and utilize functional human tissue models for studying megakaryopoiesis and platelet production.
• To gain deeper insights into the mechanisms regulating platelet release within the bone marrow.
• To identify novel therapeutic targets and innovative instruments for studying platelet production diseases.

Main Methods:

• Development of functional human tissue models that mimic the bone marrow microenvironment.
• Ex vivo studies to extrapolate findings for in vivo bone marrow functions.
• Analysis of challenges in mimicking physiological bone marrow composition and function, and validating generated platelets.

Main Results:

• Functional human tissue models show promise for studying platelet production ex vivo.
• Identified challenges in replicating bone marrow physiology and validating platelet function for clinical use.
• Laid groundwork for identifying new therapeutic strategies for platelet disorders.

Conclusions:

• Human tissue models offer a valuable platform for advancing the study of megakaryopoiesis and platelet biology.
• Overcoming challenges in model development is crucial for translating ex vivo findings to clinical applications.
• Further research using these models can lead to innovative treatments for platelet production diseases.